- Home
- PBI vs DNLI Comparison
PBI vs DNLI Comparison
Compare PBI & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBI
- DNLI
- Stock Information
- Founded
- PBI 1920
- DNLI 2013
- Country
- PBI United States
- DNLI United States
- Employees
- PBI N/A
- DNLI N/A
- Industry
- PBI Office Equipment/Supplies/Services
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PBI Miscellaneous
- DNLI Health Care
- Exchange
- PBI Nasdaq
- DNLI Nasdaq
- Market Cap
- PBI 1.9B
- DNLI 1.9B
- IPO Year
- PBI N/A
- DNLI 2017
- Fundamental
- Price
- PBI $10.52
- DNLI $14.70
- Analyst Decision
- PBI
- DNLI Strong Buy
- Analyst Count
- PBI 0
- DNLI 15
- Target Price
- PBI N/A
- DNLI $33.85
- AVG Volume (30 Days)
- PBI 2.1M
- DNLI 1.5M
- Earning Date
- PBI 05-07-2025
- DNLI 07-31-2025
- Dividend Yield
- PBI 2.18%
- DNLI N/A
- EPS Growth
- PBI N/A
- DNLI N/A
- EPS
- PBI N/A
- DNLI N/A
- Revenue
- PBI $1,998,749,000.00
- DNLI N/A
- Revenue This Year
- PBI N/A
- DNLI N/A
- Revenue Next Year
- PBI $0.40
- DNLI $256.73
- P/E Ratio
- PBI $18.21
- DNLI N/A
- Revenue Growth
- PBI 13.20
- DNLI N/A
- 52 Week Low
- PBI $4.62
- DNLI $10.57
- 52 Week High
- PBI $11.01
- DNLI $33.33
- Technical
- Relative Strength Index (RSI)
- PBI 68.33
- DNLI 55.74
- Support Level
- PBI $10.03
- DNLI $12.86
- Resistance Level
- PBI $10.55
- DNLI $14.67
- Average True Range (ATR)
- PBI 0.31
- DNLI 0.79
- MACD
- PBI 0.03
- DNLI 0.12
- Stochastic Oscillator
- PBI 96.77
- DNLI 73.60
About PBI Pitney Bowes Inc.
Pitney Bowes Inc is a technology-driven company that provides SaaS shipping solutions, mailing innovation, and financial services to clients around the globe. The company's reportable segments are SendTech Solutions and Presort Services. SendTech Solutions includes the revenue and related expenses from physical and digital mailing and shipping technology solutions, financing, services, supplies and other applications to help simplify and save on the sending, tracking and receiving of letters, parcels and flats. Presort Services includes the revenue and related expenses from sortation services to qualify large volumes of First Class Mail, Marketing Mail and Marketing Mail Flats/Bound Printed Matter for postal worksharing discounts. It derives maximum revenue from SendTech Solutions.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.